English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduTwo renowned health systems are bringing the most advanced form of radiation treatment to cancer patients in South Jersey, with the creation of the Penn Medicine |Virtua Health Proton Therapy Center in Voorhees, N.J.
Tag: Proton Therapy
A Consensus View: Proton Therapy for Breast Cancer
Bruce Haffty, MD, MS, chair of Radiation Oncology and associate vice chancellor for Cancer Programs at Rutgers Cancer Institute of New Jersey, shares insight on proton therapy, a unique type of radiation treatment, for breast cancer.
Rutgers Cancer Institute of New Jersey Expert Available for Comment on Proton Therapy for Breast Cancer
New Brunswick, N.J., August 23, 2021 – Proton therapy is a type of radiation therapy treatment that targets a tumor in a very precise way, emerging as a unique modality for breast cancer due to the ability to minimize exposure surrounding healthy…
Proton therapy induces biologic response to attack treatment-resistant cancers
Mayo Clinic researchers have developed a novel proton therapy technique to more specifically target cancer cells that resist other forms of treatment. The technique is called LEAP, an acronym for “biologically enhanced particle therapy.” The findings are published today in Cancer Research, the journal of the American Association for Cancer Research.
Hackensack Meridian Health Welcomes Radiation Oncologist with Fellowship Training in Proton Therapy
Radiation oncologist Nicholas DeNunzio, M.D., Ph.D., has joined Hackensack Meridian Health. Dr. DeNunzio has deep expertise and training in the use of standard radiation therapies, including proton therapy, which allows for the safe and precise delivery of higher doses of radiation therapy while reducing radiation exposure to surrounding tissues.
Is proton therapy the silver bullet for children with brain cancer?
How safe is proton therapy for children with brain cancer compared to the conventional x-ray radiation delivered post-surgery?
3 Awards Will Support Accelerator R&D for Medical Treatment, Miniaturization, and Machine Learning
U.S. Department of Energy awards announced in July will advance Lawrence Berkeley National Laboratory (Berkeley Lab) R&D to develop a more effective and compact particle-beam system for cancer treatment, improve particle-beam performance using artificial intelligence, and develop a high-power, rapid-fire laser system for both tabletop and large-scale applications.
Developing Detectors for Scientific Research and Medicine
Cynthia Keppel has been named a DOE Office of Science Distinguished Scientist Fellow. Based at DOE’s Thomas Jefferson National Accelerator Facility, she is one of three DOE National Laboratory scientist fellows who will receive $1 million to devote to developing better detectors for science and medicine.
Proton Therapy Lowers Risk of Side Effects in Cancer Patients Compared to Traditional Radiation
Proton therapy leads to significantly lower risk of side effects severe enough to lead to unplanned hospitalizations for cancer patients when compared with traditional radiation, while cure rates between the two groups are almost identical
Retrospective Analysis Shows Proton Therapy Well Tolerated in Patients Undergoing Breast Conserving Surgery
Investigators at Rutgers Cancer Institute of New Jersey conducted a retrospective review of patients treated with proton therapy following breast-conserving surgery and found acceptable toxicity rates along with good-to-excellent patient-reported cosmetic outcomes.
New research suggests proton radiation therapy can benefit patients with challenging liver tumors
Two new studies support and inform the use of proton radiation therapy to treat patients with hepatocellular carcinoma (HCC), a common but often fatal type of liver cancer for which there are limited treatment options. The studies were published in the International Journal of Radiation Oncology • Biology • Physics, the flagship scientific journal of the American Society for Radiation Oncology (ASTRO).